Gagnon Robert E. 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Gagnon Robert E.（CIK 1504983）在 3 家公司共报告 11 笔 SEC Form 4 内部人交易（最近一笔 2026-09-08）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-08 | Opus Genetics, Inc. (IRD) | Chief Financial Officer | 卖出 | 28,000 | $127,212 |
| 2026-07-27 | Opus Genetics, Inc. (IRD) | Chief Financial Officer | 卖出 | 7,783 | $22,942 |
| 2026-06-11 | HARVARD BIOSCIENCE INC (HBIO) | 董事 | 买入 | 16,556 | $0 |
| 2026-04-27 | Opus Genetics, Inc. (IRD) | Chief Financial Officer | 卖出 | 7,842 | $40,622 |
| 2026-01-26 | Opus Genetics, Inc. (IRD) | Chief Financial Officer | 买入 | 400,000 | $0 |
| 2025-12-18 | Verastem, Inc. (VSTM) | 董事 | 卖出 | 283 | $2,587 |
| 2025-09-18 | Verastem, Inc. (VSTM) | 董事 | 卖出 | 281 | $2,807 |
| 2025-09-11 | Opus Genetics, Inc. (IRD) | Chief Financial Officer | 买入 | 200,000 | $0 |
| 2025-07-18 | HARVARD BIOSCIENCE INC (HBIO) | 董事 | 买入 | 110,000 | $0 |
| 2025-06-20 | Verastem, Inc. (VSTM) | 董事 | 卖出 | 284 | $1,605 |
| 2025-05-27 | Verastem, Inc. (VSTM) | 董事 | 买入 | 8,333 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-08